Search

You searched for "graft"

1224 results found

Art for art’s sake

3 February 2026 |
As a junior medical student roaming the wards of St Thomas’ Hospital in the early 1990s, I was unaware that I was surrounded by a large art collection comprising over 4500 pieces. The collection is displayed throughout the building to...

UKISCRS Cornea & Cataract Day 2026

16 March 2026
United Kingdom & Ireland Society of Cataract & Refractce Surgeons Cornea & Cataract Day 2026

The Spectacle Makers’ Charity takes up the challenge of glaucoma in Nigeria

16 August 2022
The Glaucoma-NET was established by the VISION 2020 LINKS Programme in 2021 to address the high levels of irreversible blindness due to glaucoma in low-income countries. It aims to preserve the sight of people with glaucoma through bringing together patients, clinicians, researchers, NGOs and Ministries of Health, with a lasting and sustainable impact.

Glaucoma UK introduces its first ever Pitts Crick Fellow

26 March 2025 | glaucoma, digital twins, personalised medicine, technology, simulation
Glaucoma UK is delighted to announce the recipient of their first ever Pitts Crick Fellowship. This Fellowship was an important part of the charity’s 50th anniversary celebration throughout 2024. Its aim was to honour the legacy of the founder Ronald...

Working smarter not harder: How to transform eyecare delivery in the United Kingdom (part 1)

1 December 2021 | | EYE - General
Are we doing enough to meet the current demands on ophthalmic services? In part one of a two-part series (see Part 2 here), Rosalind Harrison takes a look at how efficiency has been improved in eyecare services in the US....

Nano-ophthalmology paves a new path in the future of eyecare

1 December 2022 | | EYE - General
Introduction The treatments of ocular conditions in the field of ophthalmology varies from topical to surgical procedures. The field of nanotechnology is one of the fast-growing fields of medicine, which plays an important role in turning the impossibilities of the...

Belfast briefing: Retina Day roundup from the RCOphth 2024 Annual Congress

2 August 2024 | | EYE - General
Belfast hosted this year’s Royal College of Ophthalmologists’ (RCOphth) Annual Congress, a meeting dedicated to sharing advances, knowledge and clinical practice points in ophthalmic care. This article summarises selected talks by medical and surgical retina specialists during the Retina Subspecialty...

Post-Brexit deal welcomed but leaves future relationship with EU far from settled

6 April 2021 | | EYE - General
Rod McNeil breaks down the impact of the Brexit deal on healthcare in the UK, including medicines regulation, research funding, sharing of information and the ability to work abroad. A disorderly no-deal exit from the European Union (EU) was averted...

A career in uveitis

7 December 2020 | | EYE - Vitreo-Retinal, EYE - General
As he retires from clinical practice, the author looks back on his long career in uveitis and how care of these patients has changed dramatically since his days as an undergraduate. My trainees and fellows are often bored by my...

£1.7 million funding for research into children’s eye health

14 September 2023 | Moorfields, Charity, Medical Research Foundation, Funding, Children, Adolescent
Moorfields Eye Charity and the Medical Research Foundation are working in partnership to support research into childhood and adolescent eye health, putting £1.7 million of funding into this massively underfunded area of research.

International Women’s Day 2025: In Conversation With Dr Michelle Le Cheminant

9 March 2025 | international womans day, conversation, Q&A, ophthalmology, gender
Women make up 70% of the global health and social workforce but hold only 25% of leadership roles. In ophthalmology, women represent just 25-30% of ophthalmologists. Research shows that hospitals with increased female surgeons and anesthetists have lower odds of...

Aspiration of anteriorly migrated dexamethasone implant using an 18G intravenous cannula

4 December 2025 | | EYE - Cornea, EYE - Vitreo-Retinal
Intravitreal dexamethasone (Ozurdex 0.7mg) is a biodegradable, sustained-release implant used to manage diabetic macular oedema, macular oedema secondary to retinal vein occlusion, and non-infectious posterior uveitis due to its anti-inflammatory effects and VEGF suppression [1]. While effective, the implant may...